1. Home
  2. DAC vs ARDX Comparison

DAC vs ARDX Comparison

Compare DAC & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$107.03

Market Cap

1.7B

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$5.78

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAC
ARDX
Founded
1972
2007
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
DAC
ARDX
Price
$107.03
$5.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$105.00
$15.14
AVG Volume (30 Days)
80.7K
3.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,607,000.00
Revenue This Year
N/A
$38.22
Revenue Next Year
N/A
$33.85
P/E Ratio
$4.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$65.40
$3.50
52 Week High
$118.83
$8.40

Technical Indicators

Market Signals
Indicator
DAC
ARDX
Relative Strength Index (RSI) 44.12 36.90
Support Level $91.64 $5.49
Resistance Level $118.83 $6.23
Average True Range (ATR) 3.63 0.31
MACD -1.04 -0.06
Stochastic Oscillator 4.78 13.56

Price Performance

Historical Comparison
DAC
ARDX

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include, HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia-Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: